Adam Studebaker

1.1k citations

21 papers · 885 indexed · h-index 13

Impact in

Oncology top 10%
- Cancer Cells and Metastasis
- Cytokine Signaling Pathways and Interactions
- CAR-T cell therapy research
- Cancer-related Molecular Pathways
Genetics top 10%
- Virus-based gene therapy research
- Mesenchymal stem cell research
- Glioma Diagnosis and Treatment

Papers in ⓘ

Genetics 9
- Virus-based gene therapy research 9
Animal Science and Zoology 3
- Animal Virus Infections Studies 3

Co-authors: Brett M. Hall (3 shared papers)A. Kate Sasser (3 shared papers)Amy Axel (2 shared papers)Christopher R. Pierson (8 shared papers)Brian Hutzen (7 shared papers)Nicholas J. Sullivan (1 shared paper)Stephen J. Russell (3 shared papers)Thomas J. Rosol (1 shared paper)
Journals: Neuro-Oncology (4 papers)Molecular Therapy — Oncolytics (2 papers)BMC Cancer (2 papers)Biochemical and Biophysical Research Communications (2 papers)Pediatric Blood & Cancer (1 paper)
Partner nations: United States Italy Taiwan

In The Last Decade

Adam Studebaker

21 papers receiving 873 citations

Peers

Countries citing papers authored by Adam Studebaker

Since Specialization

Citations

This map shows the geographic impact of Adam Studebaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Studebaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Studebaker more than expected).

Fields of papers citing papers by Adam Studebaker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Studebaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Studebaker. The network helps show where Adam Studebaker may publish in the future.

Co-authors

The 25 scholars most cited alongside Adam Studebaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Adam Studebaker Line = papers co-authored together Adam Studebaker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Fibroblasts Isolated from Common Sites of Breast Cancer Metastasis Enhance Cancer Cell Growth Rates and Invasiveness in an Interleukin-6–Dependent Manner Cancer Research ·Adam Studebaker, Gianluca Storci, Jillian L. Werbeck, Pasquale Sansone, A. Kate Sasser, Simona Tavolari, Tim H.‐M. Huang, Michael W.Y. Chan, Frank C. Marini, Thomas J. Rosol, Massimiliano Bonafè, Brett M. Hall	2008	198
2	Interleukin‐6 is a potent growth factor for ER‐α‐positive human breast cancer The FASEB Journal ·A. Kate Sasser, Nicholas J. Sullivan, Adam Studebaker, Lindsay Hendey, Amy Axel, Brett M. Hall	2007	187
3	Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments Cancer Letters ·A. Kate Sasser, Bethany L. Mundy-Bosse, Kristen M. Smith, Adam Studebaker, Amy Axel, Amanda M. Haidet, Soledad Fernández, Brett M. Hall	2007	102
4	MI-63: A novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53 British Journal of Cancer ·Jason Canner, Matthew Sobo, Sarah Ball, Brian Hutzen, Stephanie Deangelis, William L. Willis, Adam Studebaker, Ke Ding, Shaomeng Wang, Dajun Yang, Jiayuh Lin	2009	64
5	Treatment of medulloblastoma with a modified measles virus Neuro-Oncology ·Adam Studebaker, C. R. Kreofsky, Christopher R. Pierson, Stephen J. Russell, Evanthia Galanis, O. Raffel	2010	57
6	Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastoma Neuro-Oncology ·Adam Studebaker, Brian Hutzen, Christopher R. Pierson, Stephen J. Russell, E. Galanis, O. Raffel	2012	37
7	Oncolytic Herpes Virus rRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors Molecular Therapy — Oncolytics ·Adam Studebaker, Brian Hutzen, Christopher R. Pierson, Kellie B. Haworth, Timothy P. Cripe, Eric M. Jackson, Jeffrey R. Leonard	2017	36
8	Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine BMC Cancer ·Brian Hutzen, Christopher R. Pierson, Stephen J. Russell, Evanthia Galanis, Corey Raffel, Adam Studebaker	2012	33
9	Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin BMC Cancer ·Brian Hutzen, Hemant K. Bid, Peter J. Houghton, Christopher R. Pierson, Kimerly Powell, Anna Bratasz, Corey Raffel, Adam Studebaker	2014	32
10	ΔNp73/ETS2 complex drives glioblastoma pathogenesis— targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma Neuro-Oncology ·Maren Cam, Manish Charan, Alessandra M. Welker, Piyush Dravid, Adam Studebaker, Jeffrey R. Leonard, Christopher R. Pierson, Ichiro Nakano, Christine E. Beattie, Eugene Hwang, Madhuri Kambhampati, Javad Nazarian, Jonathan L. Finlay, Hakan Çam	2019	27
11	Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors Neuro-Oncology ·Adam Studebaker, Brian Hutzen, Christopher R. Pierson, Terri A. Shaffer, Corey Raffel, Eric M. Jackson	2015	23
12	Modulation of human dUTPase using small interfering RNA Biochemical and Biophysical Research Communications ·Adam Studebaker, William P. Lafuse, R. Kloesel, Marshall V. Williams	2004	17
13	The Herpesvirus Encoded dUTPase as a Potential Chemotherapeutic Target Current Protein and Peptide Science ·Adam Studebaker, Ganesaratnam K. Balendiran, Marshall V. Williams	2001	12
14	EphB2 activation is required for ependymoma development as well as inhibits differentiation and promotes proliferation of the transformed cell Scientific Reports ·Phylip Chen, Nathan Rossi, Samuel Priddy, Christopher R. Pierson, Adam Studebaker, Robert A. Johnson	2015	12
15	Inhibition of MEK confers hypersensitivity to X-radiation in the context of BRAF mutation in a model of childhood astrocytoma Pediatric Blood & Cancer ·Adam Studebaker, Kathryn Bondra, Star Seum, Changxian Shen, Doris A. Phelps, Christopher Chronowski, J. Leigh Leasure, Paul D. Smith, Raushan T. Kurmasheva, Xiaokui Mo, Maryam Fouladi, Peter J. Houghton	2015	12
16	Depletion of uracil-DNA glycosylase activity is associated with decreased cell proliferation Biochemical and Biophysical Research Communications ·Adam Studebaker, Maria E. Ariza, Marshall V. Williams	2005	10
17	Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolution Molecular Therapy — Oncolytics ·Jack Hedberg, Adam Studebaker, L.T. Smith, Chun‐Yu Chen, Jesse J. Westfall, Maren Cam, Amy C. Gross, Ilse Hernandez-Aguirre, Alexia Martin, Do-Yeon Kim, Ravi Dhital, Yeaseul Kim, Ryan D. Roberts, Timothy P. Cripe, Elaine R. Mardis, Kevin A. Cassady, Jeffrey R. Leonard, Katherine E. Miller	2023	8
18	Advances in the design and development of oncolytic measles viruses PubMed ·Adam Studebaker, Corey Raffel, Brian Hutzen	2015	8
19	Regulation of TORC1 by MAPK Signaling Determines Sensitivity and Acquired Resistance to Trametinib in Pediatric BRAFV600E Brain Tumor Models Clinical Cancer Research ·Fuyang Li, Kathryn Bondra, Samson Ghilu, Adam Studebaker, Qianqian Liu, Joel Michalek, Mari Kogiso, Xiao‐Nan Li, John A. Kalapurakal, C. David James, Sandeep Burma, Raushan T. Kurmasheva, Peter J. Houghton	2022	6
20	Down–Regulation of Human Deoxyuridine Triphosphate Nucleotidohydrolase (dUTPase) Using Small Interfering RNA (siRNA) Nucleosides Nucleotides & Nucleic Acids ·Marshall V. Williams, Adam Studebaker	2004	2

About Adam Studebaker

Adam Studebaker is a scholar working on Genetics, Animal Science and Zoology, Oncology, Immunology and Physiology, having authored 21 papers that have together received 885 indexed citations. Recurring topics across this work include Virus-based gene therapy research (9 papers), interferon and immune responses (6 papers), Cytokine Signaling Pathways and Interactions (3 papers), Animal Virus Infections Studies (3 papers), Cancer Cells and Metastasis (3 papers), Biochemical and Molecular Research (3 papers), Virology and Viral Diseases (3 papers) and Cytomegalovirus and herpesvirus research (2 papers). The work is most often cited by research in Oncology (444 citations), Genetics (149 citations), Cancer Research (140 citations), Genetics (195 citations) and Immunology (146 citations). Adam Studebaker has collaborated with scholars based in United States, Italy and Taiwan. Frequent co-authors include Brett M. Hall, A. Kate Sasser, Amy Axel, Christopher R. Pierson, Brian Hutzen, Nicholas J. Sullivan, Stephen J. Russell, Thomas J. Rosol, Michael W.Y. Chan and Frank C. Marini. Their work appears in journals such as Neuro-Oncology, Molecular Therapy — Oncolytics, BMC Cancer, Biochemical and Biophysical Research Communications and Pediatric Blood & Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact